Jump to main content
Jump to site search

Issue 45, 2016
Previous Article Next Article

Cocrystals of isoliquiritigenin with enhanced pharmacokinetic performance

Author affiliations

Abstract

Isoliquiritigenin (ISL) is an abundant dietary flavonoid with numerous pharmacological activities. However, isoliquiritigenin is poorly absorbed by the body which limits its clinical usage. Cocrystallization has attracted attention recently as a means of modifying unfavourable physicochemical properties of compounds. Herein, we report the synthesis of two new cocrystals of ISL: isoliquiritigenin–nicotinamide (ISL–NIC) and isoliquiritigenin–isonicotinamide (ISL–INM). To our knowledge, this is the first report of flavonoid cocrystals from a compound with a chalcone structure. The cocrystals are characterized by various techniques, including powder X-ray diffraction, Raman spectroscopy, differential scanning calorimetry and thermogravimetric analysis. Through single-crystal X-ray diffraction analysis, we investigate the crystal packing and intermolecular interactions of ISL cocrystals. The binary phase diagrams of ISL and the conformers are constructed for understanding the thermal behaviors of physical mixtures upon heating. Pharmacokinetic studies show that both of the ISL cocrystals outperform the pure form of ISL and its monohydrate with increases in bioavailabilities.

Graphical abstract: Cocrystals of isoliquiritigenin with enhanced pharmacokinetic performance

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Aug 2016, accepted on 11 Oct 2016 and first published on 03 Nov 2016


Article type: Paper
DOI: 10.1039/C6CE01809B
Citation: CrystEngComm, 2016,18, 8776-8786
  •   Request permissions

    Cocrystals of isoliquiritigenin with enhanced pharmacokinetic performance

    J. Xu, Y. Huang, S. Ruan, Z. Chi, K. Qin, B. Cai and T. Cai, CrystEngComm, 2016, 18, 8776
    DOI: 10.1039/C6CE01809B

Search articles by author

Spotlight

Advertisements